CooperCompanies Announces Release Date for Third Quarter 2022
CooperCompanies (NYSE: COO) will announce its third quarter 2022 financial results on August 31, 2022, at 4:15 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CooperCompanies (NYSE: COO) will announce its third quarter 2022 financial results on August 31, 2022, at 4:15 PM ET. A conference call will follow at 5:00 PM ET to discuss the results and other corporate developments. Participants can register for the call through a provided link and listen to a simultaneous webcast available on their website. Cooper, headquartered in San Ramon, CA, operates through CooperVision and CooperSurgical, employing over 12,000 people and selling products in more than 100 countries.
Details
News Market Reaction – COO
The recorded move for COO in the trading session of this news was +2.47%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN RAMON, Calif., July 27, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release third quarter 2022 financial results on Wednesday, August 31, 2022, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
To participate in the call please follow this link to register and receive the dial-in information. A simultaneous webcast of the call will be available through the “Investor Relations” section of the CooperCompanies website at http://investor.coopercos.com. A replay of the webcast will be available approximately two hours following the event.
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.